Skye Bioscience, Inc. Comprehensive Income
Skye Bioscience, Inc. (SKYE) reported Comprehensive Income of -$1.82 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2021-11-10
- Skye Bioscience, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-09-30 was -$1.82M.
- Skye Bioscience, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-06-30 was -$2.02M.
- Skye Bioscience, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-03-31 was -$2.16M.
- Skye Bioscience, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-09-30 was -$1.30M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month |
|---|---|---|---|
| 2021-09-30 | -$1.82M 10-Q · filed 2021-11-10 | -$3.85M derived: sum of 2 quarters · filed 2021-11-10 | -$6.01M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$2.02M 10-Q · filed 2021-08-06 | -$4.18M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | -$2.16M 10-Q · filed 2021-05-07 | ||
| 2020-09-30 | -$1.30M 10-Q · filed 2021-11-10 | -$2.72M derived: sum of 2 quarters · filed 2021-11-10 | -$5.06M 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$1.42M 10-Q · filed 2021-08-06 | -$3.76M 10-Q · filed 2021-08-06 | |
| 2020-03-31 | -$2.34M 10-Q · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |